LustGarden Foundation for Pancreatic Cancer Research

Pancreatic Cancer Research

As the largest private funder of pancreatic cancer research, we are relentlessly focused on improving patient outcomes and we are making progress every day. Thanks to separate funding to support administrative expenses, 100 percent of every donation goes directly to research.

Navigating Pancreatic Cancer

We are here to empower you to ask bold questions, seek out the best treatment options, and face the unique challenges of pancreatic cancer head-on. We want to give you the resources and information you need to make informed decisions that are best for you.

Patient Checklist

Checklist

August 1, 2018 ladmin
As overwhelming as a pancreatic cancer diagnosis is, it is important to act quickly and put a treatment plan into place. Treatment should ideally begin within one month after you receive your diagnosis. Understand your disease. Thoroughly understand what stage of pancreatic cancer you have and inquire about having your blood and tumor genetically sequenced. […]
Research

Clinical Trials Finder

July 30, 2018 ladmin
If you have been diagnosed with pancreatic cancer, a clinical trial may be your best treatment option. Many clinical trials are underway for patients in all stages of the disease and may involve new combinations of currently available drugs or new drugs that have worked in other cancers. No matter where you are in your journey, we encourage you to learn more about clinical trials.
Lets Win! Pancreatic Cancer

Let’s Win! Pancreatic Cancer

July 20, 2018 ladmin
LET’S WIN! Pancreatic Cancer A Dynamic Way to Share Information Recognizing that there is an urgent need for patients to communicate amongst themselves and with the medical community about potentially life-changing treatments and clinical trials, we are proud to be affiliated with Let’s Win. Let’s Win is an interactive online community where patients and families […]

Pancreatic Cancer Connections

July 7, 2018 ladmin
Pancreatic Cancer Connections is online social community that provides a safe space for pancreatic cancer patients and their loved ones to share their experiences, get valuable coping resources, and support one another. Patients interact with others who are facing a pancreatic cancer and can post questions to the board or message other members privately. This community forum is a valuable resource for patients, caregivers, and their loved ones to refer to at various stages of their treatment and recovery. Patients and loved ones can sign up for Pancreatic Cancer Connections at no cost and will be welcomed into an engaging and supportive community to discuss topics including treatment options, nutrition, and coping with the disease. Pancreatic Cancer Connections is hosted by Inspire, a leading healthcare social network that connects more than 1,000,000 patients and caregivers.

Lustgarten News

View All Articles

Lustgarten Mourns the Loss of RBG

Supreme Court Announces Death of Ruth Bader Ginsburg from Pancreatic Cancer

Justice Ruth Bader GinsburgWoodbury, N.Y. Sept. 18, 2020–“Today, the world joins together to mourn the loss of associate justice of the Supreme Court of the United States Ruther Bader Ginsburg and sends condolences to her family and friends,” said Kerri Kaplan, President and CEO of the Lustgarten Foundation. “While we are saddened by this devastating loss, we must uphold the legacy that she left behind both on the bench and as a pancreatic cancer survivor.” Justice Ginsburg’s long-standing career began in 1980 when she was appointed by President Jimmy Carter to the U.S. Court of Appeals for the District of Columbia Circuit, a position she retained until her appointment to the Supreme Court. During her illustrious career, she was an ardent supporter of gender equality and women’s rights and an inspiration to the cancer community as she faced her own cancer diagnoses. In 1999, Justice Ginsburg was diagnosed with colon cancer. Determined to remain on the bench during her diagnosis, she underwent surgery followed by chemotherapy and radiation. A decade later, she faced another difficult diagnosis: pancreatic cancer. Fortunately, the disease was caught early, which is often not the case with pancreatic cancer, and Justice Ginsburg was able to continue on with her duties. “In recent years, as her health deteriorated, she was seen as a pillar of strength and perseverance in the cancer community,” Kaplan said. “She will be remembered fondly not only for her imprints on the American judicial system, but as one of the great trailblazers of her time.” As the fourth-oldest Supreme Court Justice, Justice Ginsburg will be remembered as a woman of integrity who fought for gender equality and made significant legal advances for women. In 1954, she earned her B.A. in government at Cornell University and earned her law degree from Columbia Law School in 1959. During her undergraduate years, she met her husband Martin Ginsburg, whom she married shortly after graduation. The couple was married for 56 years before Martin passed away from complications from metastatic cancer.

Learn More

Honoring
Dr. Robert F. Vizza

When Dr. Robert F. Vizza started as the Lustgarten Foundation’s first President and CEO, pancreatic cancer was known as an “orphan disease”—a rare but deadly disease with little research into prevention, detection, treatment or an eventual cure. However, through Dr. Vizza’s steadfast leadership, service and dedication, the Lustgarten Foundation has directed nearly $200 million dollars into pancreatic cancer research, forever changing the orphan status and providing hope for thousands of patients, survivors and their families. Over the past 22 years, Bob has pushed relentlessly to move the science to the clinic. Therefore as part of our Gala, we are naming the Dr. Robert F. Vizza Lustgarten Clinical Accelerator Initiative in Bob’s honor. Funding for the Clinical Accelerator Initiative will allow us to initiate new clinical studies in a way that shortens the time required to move from concept to study launch and to develop smarter clinical trials that improve patient outcomes. Thank you for recognizing Dr. Vizza’s work and for your continued commitment to putting an end to pancreatic cancer.

Learn More

We’re Still Walking … Virtually

Walking on behalf of the Lustgarten Foundation has never been easier, as we have decided all remaining 2020 walks and community events will be virtual! To get started, check out our list of walks and events or search by location, then choose the one that works for you. Already registered? Fantastic! The only thing left to do is to fundraise and, if you’re up for it, recruit additional walkers. What’s a virtual walk? Glad you asked! Simply put, a virtual walk is a symbolic, online fundraising event. Just register for the virtual walk of your choice, then, on the day and time of your chosen event, wear purple and take a walk on your own or with a small group of family and friends.

Learn More

Pancreatic Cancer News

View All Articles

Cancer Projects to Diversify Genetic Research Receive New Grants

11. 9. 20 ladmin
The New York Genome Center awarded six cancer research grants this week as part of an initiative examining the role of race and ethnicity in major types of cancer. The projects will investigate a variety of cancers including pancreatic, colorectal and endometrial cancer in African-Americans; lung cancer in Asian-American patients; breast and prostate cancer in […]

UH researcher discovers susceptibility genes for pancreatic cancer

10. 9. 20 ladmin
Six novel susceptibility genes for pancreatic cancer risk have been identified by University of Hawaiʻi Cancer Center researcher Lang Wu. The study was published in Cancer Research by the American Association for Cancer Research. “Our discovery of novel candidate susceptibility genes associated with pancreatic cancer will allow us to better understand the biology and genetics of this deadly malignancy, and help us […]

Sortilin may hold the key to combat pancreatic cancer more effectively

20. 8. 20 ladmin
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel study published in The American Journal of Pathology, published by Elsevier, scientists report the discovery of an increased level of the neuroprotein sortilin in pancreatic cancer cells that may open up […]

Diabetes increases risk for pancreatic cancer, study finds

13. 8. 20 ladmin
Older adults with diabetes are nearly three times as likely to develop pancreatic cancer than the general population, according to an analysis published Thursday by JAMA Oncology. The link between diabetes and pancreatic cancer increases to seven-fold for people with the relatively rare Type 3C diabetes, which is caused by pancreatic conditions, the researchers said. The […]

Study Focuses on a Different Kind of Liquid Biopsy to Detect Cancer

13. 8. 20 ladmin
Collaborators from MSK and Weill Cornell Medicine report that tiny packages of materials released into the blood, called EVPs, may enable detection of a number of different types of cancer in the early stages. Because cancer is easier to successfully treat when it’s caught early, a major goal in cancer research is to develop new […]

COMBAT study preliminary results show response of 32% in treatment of pancreatic tumors

11. 8. 20 ladmin
Working with an international team of researchers, HonorHealth Research Institute and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, were instrumental in one of the first clinical trials showing how pancreatic cancer patients can benefit from immunotherapy, according to a four-year study published in a premier scientific journal, Nature Medicine. The […]

The first mouse model of human pancreas cancer subtypes

23. 7. 20 ladmin
Scientists at Cold Spring Harbor Laboratory (CSHL) have created the first mouse model of pancreatic cancer that recreates two subtypes of the human disease. The model, published July 23, 2020 in Cancer Discovery, will help researchers investigate why some pancreatic cancers are more aggressive than others and what causes them to progress, paving the way to […]

Study suggests new potential strategy to fight against pancreatic cancer

6. 7. 20 ladmin
A University of Michigan-led study is shedding new light on the way pancreatic cancer cells turn nearby connective tissue cells into co-conspirators in their deadly growth. The findings, which appear in Nature Metabolism, also suggest a new potential strategy against pancreatic cancer by identifying critical components of metabolic cross talk between cells that might be attacked […]

Ipsen scores FDA fast-track for Onivyde in first-line pancreatic cancer

19. 6. 20 ladmin
The FDA designation will review the use of Onivyde (liposomal irinotecan) in combination with 5- fluorouracil/leucovorin (5-FU/LV) and oxaliplatin (OX), also known as Nalirifox, in patients with previously untreated, unresectable, locally advanced and metastatic pancreatic ductal adenocarcinoma (PDAC). The fast-track programme aids the development and also expedites the review of drugs that are designed to treat serious […]

Join Us

Get Involved Today

Get inspired and connect with patients, survivors and loved ones who are all on the same journey.

Back to Top